Heme pre-treatment was shown to protect mice from lethal endotoxemia and sepsis induced by LPS or CLP, respectively, and this effect was related in part to reduction of pro-inflammatory cytokines and normalization of high mobility group box-1 (HMGB1) protein levels [79,134]. This evidence concerns the gene HMGB1 and serum lipopolysaccharide activity.